218 related articles for article (PubMed ID: 12929470)
1. Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage.
Laurent S
J Hypertens Suppl; 2003 Jun; 21(3):S11-8. PubMed ID: 12929470
[TBL] [Abstract][Full Text] [Related]
2. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
Laurent S
J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
Mourad JJ; Le Jeune S
Curr Med Res Opin; 2009 Sep; 25(9):2271-80. PubMed ID: 19627177
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.
Asmar RG; London GM; O'Rourke ME; Mallion JM; Romero R; Rahn KH; Trimarco B; Fitzgerald D; Hedner T; Duprez D; De Leeuw PW; Sever P; Battegay E; Hitzenberger G; de Luca N; Polónia P; Bénétos A; Chastang C; Ollivier JP; Safar ME;
J Hypertens Suppl; 2001 Nov; 19(4):S15-20. PubMed ID: 11848258
[TBL] [Abstract][Full Text] [Related]
5. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Waeber B
J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R;
J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
Chalmers J; Castaigne A; Morgan T; Chastang C
J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
[TBL] [Abstract][Full Text] [Related]
8. Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure.
Safar ME; Myers MG; Leenen F; Asmar R
J Hypertens; 2002 Aug; 20(8):1653-61. PubMed ID: 12172328
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of a fixed low-dose perindopril/indapamide combination in essential hypertension. A randomised controlled study.
Mallion JM; Chastang C; Unger P
Clin Exp Hypertens; 2000 Jan; 22(1):23-32. PubMed ID: 10685722
[TBL] [Abstract][Full Text] [Related]
10. ADVANCE: breaking new ground in type 2 diabetes.
Chalmers J; Perkovic V; Joshi R; Patel A
J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
[TBL] [Abstract][Full Text] [Related]
11. New Premier study suggest Preterax as a first-line antihypertensive.
Cardiovasc J S Afr; 2004; 15(1):40-1. PubMed ID: 15095752
[No Abstract] [Full Text] [Related]
12. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol.
London GM; Asmar RG; O'Rourke MF; Safar ME;
J Am Coll Cardiol; 2004 Jan; 43(1):92-9. PubMed ID: 14715189
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.
Mourad JJ; Waeber B; Zannad F; Laville M; Duru G; Andréjak M;
J Hypertens; 2004 Dec; 22(12):2379-86. PubMed ID: 15614033
[TBL] [Abstract][Full Text] [Related]
14. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
15. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
de Luca N; Mallion JM; O'Rourke MF; O'Brien E; Rahn KH; Trimarco B; Romero R; De Leeuw PW; Hitzenberger G; Battegay E; Duprez D; Sever P; Safar ME
Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062
[TBL] [Abstract][Full Text] [Related]
16. Persistence of the antihypertensive effect of low-dose combination therapy in mild hypertension.
Myers MG; Leenen FH;
Blood Press; 2006; 15(6):325-32. PubMed ID: 17472022
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a very-low-dose combination of perindopril and indapamide--preterax compared with cilazapril monotherapy in patients with inadequate blood pressure control--a randomized, double-blind, add-on study.
Sung SH; Wu TC; Lin SJ; Chen JW
J Chin Med Assoc; 2008 May; 71(5):247-53. PubMed ID: 18490229
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Tolerability of Fixed-Dose Combination Perindopril/Indapamide in Hypertensive Patients with a History of Stroke or Transient Ischemic Attack: PICASSO Trial.
Dézsi CA; Farsang C;
Adv Ther; 2018 May; 35(5):644-654. PubMed ID: 29748913
[TBL] [Abstract][Full Text] [Related]
19. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.
Asmar RG; London GM; O'Rourke ME; Safar ME;
Hypertension; 2001 Oct; 38(4):922-6. PubMed ID: 11641310
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment].
Andréjak M; Zannad F; Laville M; Duru G; Mourad JJ; Waeber B
Therapie; 2003; 58(4):351-2. PubMed ID: 14679674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
